Bipolar disorder and alcohol use disorder co-occur at rates higher than almost any other diagnostic pairing. Alcohol interferes with mood stabilizers, destabilizes both manic and depressive episodes, and accelerates cycling over time. Treating only one condition while leaving the other unaddressed is not a treatment plan: it is a recipe for relapse. At iRely, both are treated together from day one.
Alcohol Use Disorder and Bipolar Disorder: Treating the Full Picture
Call (818) 806-0933 · Available 24/7 · Confidential
Why Bipolar Disorder and Alcohol Use Disorder So Often Co-Occur
The overlap between bipolar disorder and alcohol use disorder is not coincidental. Several distinct mechanisms drive the high co-occurrence rate, and understanding them matters for treatment.
During depressive phases, alcohol is frequently used as self-medication. It temporarily dulls the flat, hopeless quality of bipolar depression, provides sedation, and offers short-term relief from the cognitive rumination that characterizes low mood. The relief is real but brief, and the rebound worsens the depressive episode.
During manic or hypomanic phases, the picture is different. Disinhibition and impulsivity are core features of mania, and alcohol amplifies both. A person in a manic episode may drink heavily because their usual inhibitions are reduced, their judgment is impaired, and the stimulating effect of alcohol fits the elevated mood state they are already in. This creates a reinforcing loop.
How Alcohol Worsens Bipolar Disorder
Alcohol does not simply add a second problem on top of bipolar disorder. It actively makes bipolar disorder harder to manage across multiple mechanisms.
Sleep Disruption
Alcohol fragments sleep architecture. Deep sleep and REM cycles are disrupted even from moderate drinking. Sleep disruption is one of the most reliable triggers for bipolar episodes, making alcohol one of the most potent destabilizers available.
Medication Interference
Lithium, valproate, lamotrigine, and other mood stabilizers depend on consistent absorption and metabolism. Alcohol interferes with all of these, reducing therapeutic efficacy and in some cases increasing toxicity risk. A person on lithium who drinks regularly may never achieve stable therapeutic levels.
Increased Impulsivity
Both bipolar disorder and alcohol use disorder impair impulse control independently. Together, the effect is compounded. This increases risk of self-harm, reckless behavior, and decisions that damage relationships, employment, and recovery.
Prolonged Depressive Episodes
Alcohol is a central nervous system depressant. In a person with bipolar depression, regular alcohol use deepens and prolongs the depressive phase. What might have been a two-week episode can extend for months when alcohol is present.
Mixed State Triggering
Mixed states, where features of mania and depression occur simultaneously, are the most dangerous phase of bipolar disorder in terms of suicide risk. Alcohol use is a documented precipitant of mixed episodes, making it particularly hazardous for people with this diagnosis.
iRely’s Dual-Diagnosis Bipolar and AUD Treatment
Treating bipolar disorder and alcohol use disorder together requires more coordination than simply running two separate treatment tracks in parallel. At iRely, integrated dual-diagnosis care means the psychiatric and addiction treatment teams work from a shared clinical picture from the first day of admission.
Medication management begins immediately. The priority in early treatment is mood stabilization: without a stabilized mood baseline, therapeutic work on trauma, cognition, and relapse prevention is far less effective. This means the psychiatric team may adjust or initiate mood stabilizer therapy before other psychological work begins in depth.
Detox requires particular care when a client is on mood stabilizers. Alcohol withdrawal can interact with medications like lithium and valproate, and the clinical team monitors both the withdrawal process and medication levels closely throughout detox. The goal is to get through withdrawal safely while keeping mood stabilization on track rather than pausing it.
The coordination between teams also extends to aftercare. Discharge planning includes psychiatric follow-up with appropriate handoffs, medication continuity, and outpatient support structures that understand both conditions. A referral to a standard outpatient program that does not address bipolar disorder is not a complete discharge plan.
Questions about dual-diagnosis treatment for bipolar disorder and AUD? We are here.
Frequently Asked Questions
Can I stay on my bipolar medications during alcohol rehab?
Yes. Continuing mood stabilizer therapy during alcohol rehab is not only permitted at iRely, it is a clinical priority. Stopping bipolar medications during detox or early treatment would destabilize mood at exactly the moment when stability is most needed. The psychiatric team reviews all current medications at admission and manages them throughout treatment, including during detox when monitoring for interactions is especially important.
How do you tell apart bipolar depression from alcohol-induced depression?
This is one of the more clinically demanding questions in dual-diagnosis assessment. Alcohol-induced depressive symptoms typically begin to resolve within days to weeks of sustained sobriety. Bipolar depression persists, recurs in a pattern consistent with the person’s mood history, and responds to mood-specific interventions rather than to sobriety alone. The clinical team at iRely takes a detailed psychiatric and substance use history at intake, and assessment of mood diagnosis is revisited as early sobriety progresses. A diagnosis made on day one of treatment may be refined as the picture becomes clearer.
Is my bipolar harder to treat because I also drink?
Bipolar disorder with co-occurring AUD does have a more complex clinical course than either condition alone. Research consistently shows higher rates of rapid cycling, mixed episodes, and treatment resistance in people with both diagnoses. This does not mean treatment is ineffective: it means treatment needs to address both conditions together rather than sequentially. When integrated dual-diagnosis care is provided, outcomes improve significantly compared to treating each condition separately or treating one while ignoring the other.
What happens during detox if I am on mood stabilizers?
Detox is medically supervised at iRely and the team is experienced in managing withdrawal in the presence of psychiatric medications. For lithium in particular, alcohol withdrawal can affect hydration and electrolyte balance in ways that shift lithium levels, so monitoring is close. Valproate and other anticonvulsants require similar attention. The goal is to manage withdrawal safely while keeping mood stabilizer therapy intact and effective throughout the process.
How long does it take to stabilize mood after stopping alcohol?
The timeline varies considerably by individual. Alcohol-induced mood symptoms often improve noticeably within the first one to two weeks of sobriety. However, true bipolar stabilization in someone who has been drinking heavily may take several weeks to months, particularly if medication adjustments are needed. Some of what looks like uncontrolled bipolar cycling in the context of active drinking becomes more manageable with sustained sobriety, while the underlying bipolar disorder itself requires ongoing psychiatric management beyond the residential stay.
Both Conditions. One Integrated Program.
Bipolar disorder and alcohol use disorder require treatment that accounts for both. iRely’s dual-diagnosis program is built for exactly this.
Available 24/7 · Private · Los Angeles, CA
Sources & References
National Institute on Alcohol Abuse and Alcoholism (NIAAA). Alcohol and Bipolar Disorder: Co-Occurring Conditions.
Frye, M.A., & Salloum, I.M. (2006). Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations. Bipolar Disorders, 8(6), 677-685.
Strakowski, S.M., et al. (2000). The impact of substance abuse on the course of bipolar disorder. Biological Psychiatry, 48(6), 477-485. American Journal of Psychiatry.






